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Structure of Amantadine-Bound M2 Transmembrane Peptide of Influenza
A in Lipid Bilayers from Magic-Angle-Spinning Solid-State NMR: The
Role of Ser31 in Amantadine Binding
Abstract
The M2 proton channel of influenza A is the target of the antiviral drugs amantadine and rimantadine, whose
effectiveness has been abolished by a single-site mutation of Ser31 to Asn in the transmembrane domain of
the protein. Recent high-resolution structures of the M2 transmembrane domain obtained from detergent-
solubilized protein in solution and crystal environments gave conflicting drug binding sites. We present
magic-angle-spinning solid-state NMR results of Ser31 and a number of other residues in the M2
transmembrane peptide (M2TMP) bound to lipid bilayers. Comparison of the spectra of the membrane-
bound apo and complexed M2TMP indicates that Ser31 is the site of the largest chemical shift perturbation
by amantadine. The chemical shift constraints lead to a monomer structure with a small kink of the helical axis
at Gly34. A tetramer model is then constructed using the helix tilt angle and several interhelical distances
previously measured on unoriented bilayer samples. This tetramer model differs from the solution and crystal
structures in terms of the openness of the N-terminus of the channel, the constriction at Ser31, and the side-
chain conformations of Trp41, a residue important for channel gating. Moreover, the tetramer model suggests
that Ser31 may interact with amantadine amine via hydrogen bonding. While the apo and drug-bound
M2TMP have similar average structures, the complexed peptide has much narrower linewidths at
physiological temperature, indicating drug-induced changes of the protein dynamics in the membrane.
Further, at low temperature, several residues show narrower lines in the complexed peptide than the apo
peptide, indicating that amantadine binding reduces the conformational heterogeneity of specific residues.
The differences of the current solid-state NMR structure of the bilayer-bound M2TMP from the detergent-
based M2 structures suggest that the M2 conformation is sensitive to the environment, and care must be taken
when interpreting structural findings from non-bilayer samples.
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Abstract
The M2 proton channel of influenza A is the target of the antiviral drugs amantadine and
rimantadine, whose effectiveness has been abolished by a single-site mutation of Ser31 to Asn in
the transmembrane domain of the protein. Recent high-resolution structures of the M2
transmembrane domain obtained from detergent-solubilized protein in solution and crystal
environments gave conflicting drug binding sites. We present magic-angle-spinning solid-state
NMR results of Ser31 and a number of other residues in the M2 transmembrane peptide (M2TMP)
bound to lipid bilayers. Comparison of the spectra of the membrane-bound apo and complexed
M2TMP indicates that Ser31 is the site of the largest chemical shift perturbation by amantadine.
The chemical shift constraints lead to a monomer structure with a small kink of the helical axis at
Gly34. A tetramer model is then constructed using the helix tilt angle and several interhelical
distances previously measured on unoriented bilayer samples. This tetramer model differs from
the solution and crystal structures in terms of the openness of the N-terminus of the channel, the
constriction at Ser31, and the sidechain conformations of Trp41, a residue important for channel
gating. Moreover, the tetramer model suggests that Ser31 may interact with amantadine amine via
hydrogen bonding. While the apo and drug-bound M2TMP have similar average structures, the
complexed peptide has much narrower linewidths at physiological temperature, indicating drug-
induced changes of the protein dynamics in the membrane. Further, at low temperature, several
residues show narrower lines in the complexed peptide than the apo peptide, indicating that
amantadine binding reduces the conformational heterogeneity of specific residues. The differences
of the current solid-state NMR structure of the bilayer-bound M2TMP from the detergent-based
M2 structures suggest that the M2 conformation is sensitive to the environment, and care must be
taken when interpreting structural findings from non-bilayer samples.
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Introduction
The M2 protein of influenza A virus forms a tetrameric proton channel that is the target of
the antiviral drugs amantadine and rimantadine 1. The drugs were effective until recently,
when a single-site mutation of S31N in the transmembrane domain of the protein caused
complete resistance of the viruses to the drugs 2. The M2 proton channel is important for
viral replication. After the virus enters the infected cell by endocytosis, the proton channel
acidifies the viral core, which triggers the dissociation of the virus matrix and subsequent
viral gene expression 3. With 97 amino acids, the M2 protein is small compared to typical
ion channels, thus it is an excellent system for elucidating the structure-function relationship
of ion channels. Extensive mutagenesis, electrophysiological 4; 5 and sedimentation
experiments 6 have been carried out to determine the low-resolution structure and stability of
this proton channel. Elucidating the high-resolution structure and the difference between the
drug-free and drug-bound states is the next natural challenge that is important not only for
developing new inhibitors to curb influenza infection but also for understanding the
fundamental biophysics of ion channels.
The transmembrane domain of the M2 protein spanning residues 22 to 46 (Figure 1a)
contains a histidine and a tryptophan that are crucial for proton conduction and gating 7; 8.
This domain exhibits channel activity 9 and forms a parallel four-helix bundle with left-
handed crossing angles. The residues facing the channel lumen versus the lipids have been
identified through experiments probing the effects of mutation on proton currents and
amantadine inhibition 10. The main channel-facing residues, V27, A30, G34 and H37, fall
onto the a and d positions of a heptad repeat (Figure 1b). The b, c, and f positions of the
heptad repeat face the lipids, while the e and g positions occupy the helix-helix interfaces.
Apart from the transmembrane domain, the segment of the protein spanning residues 44–60
forms a membrane-proximal amphipathic helix that is important for channel stability 11 and
is recently found to be involved in pH activation 12.
Recently, two high-resolution structures of portions of the M2 protein containing the
transmembrane domain were reported simultaneously 13; 14. One structure was obtained by
X-ray crystallography and the other by solution NMR. The X-ray structure was determined
on amantadine-bound M2(22–46) in the detergent octyl-βD-glucopyranoside (OG) 14. The
solution NMR structure was determined on rimantadine-bound M2(18–60) solubilized in
DHPC micelles 13. Strikingly, the two structures showed very different drug binding sites:
the solution NMR structure showed rimantadine to be bound at the helix-helix interfaces of
the tetramer near the C-terminus of the transmembrane domain, while the crystal structure
showed amantadine bound to the channel lumen near the N-terminus. In addition, the helix
orientation and the sidechain conformations of the two structures differ substantially 15.
These structural differences underscore the importance of examining the M2 transmembrane
peptide structure using an independent technique and doing so in the most biologically
relevant environment of lipid bilayers. Detergent micelles are known to cause curvature
stress to membrane proteins and have been documented to affect the structure of proteins
compared to bilayer-bound samples 16. Similarly, crystallizing hydrophobic membrane
proteins in a sparse matrix of detergent molecules leaves open the question of how different
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the structure is from the bilayer-bound state. For these reasons, solid-state NMR (SSNMR)
spectroscopy, which can be readily applied to lipid bilayers and other semi-solids, is the
preferred method for determining the high-resolution structures of membrane proteins.
Until recently, the majority of SSNMR data on the M2 transmembrane peptide (M2TMP)
consisted of static 15N chemical shift anisotropies and N-H dipolar couplings measured on
uniaxially aligned membrane samples. These data yielded very precise orientation angles of
the M2TMP helices in the lipid bilayer 17; 18. However, the 15N NMR constraints do not
report the sidechain conformation nor the interhelical packing of the tetramer. Further,
information on the backbone structure is only inferred by pattern recognition of the 2D N-H
dipolar and 15N chemical shift correlation spectra.
We recently undertook a magic-angle-spinning (MAS) SSNMR study of the structure and
dynamics of M2(22–46) in lipid bilayers. Several types of structural information have been
obtained so far. First, isotropic 13C and 15N chemical shifts of eight residues in the
transmembrane domain (L26, V27, A29, A30, I33, G34, I35, and L38) were measured and
compared between the apo and amantadine-complexed states 19 to determine structure
perturbation by the drug. Second, ϕ, ψ and χ1 torsion angles were directly measured at
selected residues by dipolar correlation experiments to quantify the peptide conformation.
Third, we measured the helix orientations using unoriented membrane samples and found
small differences between the apo and drug-bound peptide, as well as different tilt angles in
lipid bilayers of different thicknesses 20; 21. Fourth, the peptide dynamics were probed by 2H
quadrupole NMR and various dipolar coupling and chemical shift anisotropy measurements,
and were found to be dramatically altered by drug binding 20. Finally, we measured
interhelical distances at V27, A30, L38, and W41 using 19F-labeled M2TMP to constrain the
helix packing in the tetrameric bundle 22; 23. These SSNMR results were obtained from
M2TMP bound to hydrated and unoriented DLPC, DMPC or POPC membranes, which are
more natural environments for membrane proteins than detergents.
In this work, we report the chemical shifts of Ser31, Val28 and Leu36, and propose a
backbone structural model of M2TMP using all SSNMR constraints obtained so far. Ser31
has been postulated to be the main residue involved in amantadine binding. MD simulations
suggested that the Ser31 hydroxyl group forms hydrogen bonds with the amantadine
amine 24. This was supported by neutron diffraction experiments that showed amantadine to
be positioned between Val27 and Ser31 25. Mutation of Ser31 to Asn gives rise to the main
drug-resistant mutant in current influenza A viruses. Thus, knowledge of Ser31 conformation
in M2TMP is important for understanding how amantadine blocks the channel. The
availability of chemical shifts for a contiguous segment of the peptide allows us to deduce
the (ϕ, ψ) torsion angles of the protein using the well established relation between protein
conformation and NMR chemical shifts 26. From this chemical shift constrained monomer
structure, we constructed a tetramer model of the transmembrane domain using several
interhelical distances measured previously. We compare this MAS-NMR model with the
solution NMR, X-ray, and 15N orientation-NMR structures, and suggest the binding site of
amantadine.
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Results
13C chemical shifts of VSL-M2TMP without and with amantadine
Figure 2 shows the lipid-suppressed 13C MAS spectra of V28, S31, L36-labeled M2TMP
without (a, c) and with amantadine (b, d). The lipid background signals were suppressed by
a 13C-13C DQ filter in (a, b) and a 15N-13C heteronuclear dipolar filter in (c, d). For the N-C
filtered spectra, only the directly bonded Cα signals are selected due to the short N-C
recoupling time used. All spectra were measured at 243 K, in the gel phase of the
membrane.
The main 13C chemical shift difference caused by amantadine occurs at S31 Cα and Cβ: the
two sites overlap completely in the apo-M2TMP spectrum (a) but become partly resolved in
the amantadine-complexed spectrum (b). In addition, the 15N-13C filtered spectra in (c, d)
show a narrower S31 Cα peak for the complexed peptide than the apo peptide. At low
temperature where peptide motion is frozen, NMR linewidths reflect conformational
distribution. Thus, the narrower Cα line of the complexed peptide indicates reduced
conformational heterogeneity at S31 upon drug binding (see below).
Figure 3 shows the 2D 13C-13C DQF-COSY spectra to illustrate the unambiguous
assignment of the 13C chemical shifts. The 2D spectra further illustrate the striking
difference of S31 chemical shifts between the apo- and amantadine-complexed M2TMP:
while the apo peptide does not resolve the S31 Cα and Cβ peaks near 61 ppm, the
complexed peptide shows clear off-diagonal intensities indicative of chemical shift
separation between Cα and Cβ (b). On the other hand, the S31 Cβ/CO cross peaks are
unchanged by amantadine (c). Since protein secondary structures give opposite-signed
secondary shifts between Cβ on one hand and Cα and CO on the other, the absence of
opposite Cα and CO shift changes from the Cβ shift change suggests that the cause for the
Cβ change is packing interaction with amantadine rather than (ϕ, ψ) angle changes of the
S31 backbone.
To confirm the S31 Cβ chemical shift, we carried out a 1D CH2-spectral editing experiment.
The experiment selectively detects CH2 groups such as Ser Cβ while suppressing the signals
of all CH groups such as backbone Cα’s. Figure 4 compares the CH2-edited spectra (b, d)
with the 13C CP spectra (a, c) of the apo and complexed M2TMP. The unfiltered spectra
contain all labeled peptide 13C signals as well as natural abundance lipid 13C signals; thus
they are less resolved than Figure 2. The CH2 filter suppressed the V28 and L36 Cα signals
but retained S31 Cβ, L36 Cβ, and the main lipid CH2 peaks. The method does not
completely suppress the mobile CH3 groups, however their chemical shifts do not overlap
with Ser Cβ. The CH2-edited spectra of the apo and complexed peptide (b, d) confirm the
1.0 ppm upfield shift of the S31 Cβ peak upon amantadine binding.
In addition to S31, V28 Cα and CO show significant chemical shift changes in the 2D
spectra (Figure 3c). The CO frequency increased by 1.4 ppm while the Cα chemical shift
increased by 0.7 ppm (Table 1). These downfield shift changes are consistent with a more
ideal helical conformation in the presence of amantadine. Moreover, the CO chemical shift
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is sensitive to hydrogen bonding 27; thus the larger increase of the CO chemical shift over
Cα suggests that amantadine may perturb the hydrogen-bond network around V28.
15N chemical shifts of VSL-M2TMP without and with amantadine
Low-temperature 1D 15N MAS spectra of the apo and complexed VSL-M2TMP are shown
in Figure 5. The assignment of the 15N peaks is based on 2D 15N-13C correlation spectra
shown in Figure 6 below. Both the 15N chemical shifts and 15N linewidths show dramatic
changes upon amantadine binding. The V28 and S31 15N peaks move downfield, and all
three sites are narrowed by a factor of two. The drug-complexed peptide has FWHM of 2.0
ppm for all three sites, while the apo peptide linewidths range from 3.5 – 5.3 ppm (Table 2).
2D 15N-13C correlation spectra are shown in Figure 6 to provide definitive evidence of
structure perturbation by amantadine. Consistent with the 13C data, the most
pronounced 15N chemical shift change occurs at S31 (6.7 ppm), followed by V28, which has
a more modest but still significant 15N shift increase of 3.1 ppm. Similar to the 13C data,
L36 exhibits little change in its 15N chemical shift.
Chemical shift perturbation at the M2TMP core
Table 1 summarizes all 13C and 15N chemical shifts measured for eleven residues, including
L26, V27, V28, A29, A30, S31, I33, G34, I35, L36, and L38. This table extends the one
recently reported 19 by the addition of V28, S31 and L36 chemical shifts, the addition of
carbonyl chemical shifts for all residues, and the more accurately measured sidechain methyl
chemical shifts 28. Figure 7a plots the average chemical shift change per residue due to
amantadine binding:
where n is the number of chemical shift values available in each residue. Both the 13C
and 15N chemical shifts are included, and the absolute value of the chemical shift difference
is summed to avoid cancellation of positive and negative shift changes. Figure 7a shows
three distinct local maxima of chemical shift perturbation: S31, G34 and V28, with average
chemical shift changes of 2.1 ppm, 1.1 ppm, and 0.9 ppm, respectively.
Conformational distributions at V28, S31 and L36
While isotropic chemical shifts report the average conformation, linewidths of frozen
proteins indicate the conformational distribution. Apparent linewidths (Δ*) directly read off
from the spectra are indicative of conformational heterogeneity, while homogeneous
linewidths (Δ) result from T2 relaxation, which is induced by microsecond-timescale
molecular motions that modulate the nuclear spin interactions. The homogeneous linewidths
can be measured using spin echo experiments and are related to T2 by Δ = 1/πT2. We
extracted the 15N and 13C apparent linewidths from 2D 13C-13C and 15N-13C correlation
spectra where all signals are resolved. Low temperature spectra are used since they capture
all conformations present in the fluid membrane. Table 2 shows that the apparent linewidths
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of most sites in V28, S31 and L36 are similar between the apo and complexed peptide, with
the exception of all amide 15N sites and S31 Cα and Cβ.
To obtain the 13C homogeneous linewidths, we measured the T2 relaxation times under a 1H
decoupling field of 71 kHz. 1H-decoupled heteronuclear T2 is mainly sensitive to motions
on the timescale of the inverse of the decoupling field, which is thus ~ 10 μs. Table 2 shows
that the 13C homogeneous linewidths are identical between the apo and complexed peptide
within experimental uncertainty, indicating that all peptide motion is frozen at 243 K and
does not cause different relaxation between the apo and complexed states. Thus, the
narrower Δ* of S31 in the complexed peptide must be attributed to reduced conformational
heterogeneity due to drug binding.
Amantadine-induced changes of M2TMP dynamics
Complementing the low-temperature chemical shift and linewidth data, we measured
the 13C spectra of M2TMP in the liquid-crystalline phase of the lipid bilayer to obtain
information on the molecular motion of the protein. Previous data on eight other labeled
residues found across-the-board line narrowing by amantadine at high temperature 19. This
is now observed at V28, S31, and L36 as well. Figure 8 shows the 13C CP-MAS spectra of
apo and complexed VSL-M2TMP in DLPC bilayers from 243 K to 313 K. At 243 K, the
spectra show strong intensities characteristic of immobilized molecules for both the apo and
complexed M2TMP. When the temperature increased to 283 K, near the phase transition
temperature of the DLPC bilayer, the peak intensities decrease significantly for both
samples, indicating intermediate-timescale motion. Increasing the temperature to the near-
physiological 313 K partially recovered the intensities of both samples, but the amantadine-
complexed peptide exhibits stronger CP intensities than the apo-peptide, especially for
methylene groups such as L36 Cβ and S31 Cβ.
To probe fluid-phase dynamics of M2TMP, we measured the 13C T2 of the peptide at 303 K
using the Hahn-echo experiment and compared them between the apo and complexed states.
Table 3 shows that the 13C T2 values increase by 1.5 – 4.0 fold upon drug binding,
consistent with what was observed at other residues 19. Plotting the fractional increase of
the 13C T2 for the eleven residues as
we find two local maxima, V27 and S31 (Figure 7b).
Dependence of M2 structural changes on amantadine concentration and specificity of the
structure changes
The above amantadine-induced chemical shift changes were measured on membrane
samples prepared from buffers containing 10 mM amantadine. 1H solution NMR analysis of
the supernatant after the membrane is pelleted showed that the amount of amantadine bound
to the membrane typically corresponded to a M2 : amantadine molar ratio of ~1 : 10. This is
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well in excess of the expected stoichiometric M2 : amantadine ratio, which is either 4 : 1
based on the crystal structure or 1: 1 based on the solution NMR structure. The use of excess
amantadine is largely due to the concern that the lipophilic drug, which readily partitions
into the lipid membrane from the aqueous solution 29; 30; 31, may not all end up in the
channel. Nevertheless, the question arises as to whether the observed M2 chemical shift
changes result from non-specific effects of amantadine on the lipid bilayer that then
indirectly change the peptide structure, or whether it is due to direct amantadine-peptide
interactions. To address this question, we prepared a VSL-M2TMP sample in DLPC
bilayers with a much lower M2 : amantadine molar ratio of 1 : 2, by directly titrating a
quantitative amount of amantadine solution into the M2 membrane pellet. The resulting 2D
spectrum (Fig. 9c) shows that 70% of the S31 15N-13Cα peak has shifted to the bound
position. The 30% remaining unshifted signal can be attributed to channels without
amantadine, implying that some amantadine is dispersed in the rest of the lipid bilayer. The
observation of the same chemical shift perturbation at much lower amantadine levels
confirm that the structural changes we detect at high concentration result from direct drug-
protein interactions rather than non-specific lipid-mediated effects.
A related question is whether amantadine causes the M2 13C T2 relaxation time changes
(Figure 7b) by indirect and non-specific changes of the membrane dynamics. To answer this
question, we prepared two DLPC samples without the M2 peptide. One sample does not
contain amantadine and the other contains 10 mM amantadine in the buffer during vesicle
formation. The 13C T2 relaxation times of the two DLPC samples were measured at 313 K
by direct polarization Hahn echo experiments, in which identical 1H decoupling field
strengths (30 kHz) were used to ensure that the motion is probed on the same timescale.
Figure 10 shows the fractional T2 changes for all resolved DLPC carbon sites. It can be seen
that all sites except the headgroup Cβ experience negligible T2 changes of less than ±10%
upon amantadine binding. Moreover, most DLPC sites show a decrease of 13C T2, opposite
to the trend for M2TMP. Thus, amantadine does not significantly impact the lipid dynamics,
and the dynamic changes of M2TMP are specifically due to peptide-drug interactions.
Discussion
The goals of this study are two fold: obtain a chemical shift constrained backbone structure
of M2TMP in the absence and presence of amantadine, and determine the size and nature of
the drug-induced conformational change, particularly at Ser31. With the consolidation of
the 13C and 15N chemical shifts for eleven consecutive residues in the core of the peptide,
we can now use the TALOS program to predict the backbone torsion angles of the M2
peptide in the lipid bilayer.
Backbone structure of M2TMP monomer
The TALOS predicted (ϕ, ψ) torsion angles of M2TMP based on the 13C and 15N chemical
shifts are shown in Figure 11 and tabulated in Table S1 in Supplementary Materials. TALOS
requires the chemical shifts of three consecutive residues to predict the torsion angles of the
central residue. Since I32 and H37 have not been labeled in our studies but data for their
neighboring residues are available, we used database ideal helical chemical shifts for these
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two residues as placeholders in order to extract the (ϕ, ψ) angles of their neighboring
residues. The torsion angles of I32 and H37 are thus not entirely constrained (shaded points
in Figure 11).
The chemical shift changes listed in Table 1 indicate a number of (ϕ, ψ) changes, although
none of them are large enough to alter the basic helical nature of the protein. The first region
of change is V27-V28, and the second is A30-S31. Interestingly, while the chemical shifts of
V27 and A30 themselves are not significantly perturbed, the larger chemical shift changes of
their C-terminal residues, V28 and S31, translated into significant (ϕ, ψ) changes at V27 and
A30. In particular, the large 15N chemical shift changes of S31 and V28 indicate that the ψ
angle of A30 and V27, respectively, are significantly perturbed.
The G34-I35 pair is the third region of (ϕ, ψ) perturbation that merits attention. Not only do
both residues show clear chemical shift perturbations, but also two sets of G34 15N and 13C
chemical shifts are present in the complexed peptide (Table 1). We denote the set with an
upfield 15N shift of 106.3 ppm as amt1, and the set with a downfield 15N chemical shift of
109.7 ppm as amt2. The amt1 chemical shifts are similar to the apo values, suggesting that a
population of peptide either does not bind or only weakly binds amantadine. In contrast, the
amt2 chemical shifts are significantly different from the apo values, and cause larger G34 ϕ
and I35 ψ changes (Figure 11). Overall, the TALOS predicted (ϕ, ψ) angle differences
between the apo- and amt2 forms of M2TMP are on average (1.8°, 2.8°).
Figure 12 shows the monomer structure of the M2TMP backbone based on the TALOS (ϕ,
ψ) angles. The apo structure is shown in black and gray and the amt2 structure in blue and
cyan. For residues 39 down to the end of the helix, where no experimental chemical shifts
are available, we used the helical torsion angles of (−59°, −44°) for both the apo and
complexed peptide. Figure 12 shows that both helices are relatively ideal. The side views of
the two models are oriented such that the N-terminus half of the helix above G34 has a tilt
angle of 35° for the apo peptide and 38° for the amantadine-bound peptide. These tilt angles
were measured on hydrated vesicle samples by 15N NMR 19; 20; 21. When the N-terminal
segments of the two helices are superimposed, it becomes apparent that the amt2 and apo
helices diverge in the orientation of the segment C-terminal to G34. Comparing the helical
axis for residues 27–33 with the helical axis for residues 35–41, we find a kink of 8° for the
apo peptide and 5° for the amt2 helix. The helical axis orientations were calculated as the
average N-H vector orientation of each 7-residue segment, which approximately complete
two turns of the helix.
15N chemical shift anisotropies and N-H dipolar couplings have been measured on M2TMP
in glass-plate aligned DMPC/DMPG membranes using static NMR techniques. These data
indicated a pronounced helix kink of 13° for the drug-complexed M2TMP 17. The site of the
kink is G34, in good qualitative agreement with the current chemical shift data that indicate
structure perturbation at G34-I35. However, the kink from the oriented-sample NMR data is
much larger than deduced from the current unoriented MAS samples. While static 15N
anisotropic couplings are very sensitive to helix orientations, it is possible that glass-plate
samples may exert additional influences on the protein orientation through mechanical stress
and hydration. In comparison, the unoriented vesicle samples should place much less stress
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on membrane proteins and thus provide a useful check of the protein orientation. Moreover,
the membrane thickness may affect the helical kink. The aligned membrane experiments
were done in DMPC and DMPG lipids while the current experiments were conducted in the
thinner DLPC bilayers.
The recent solution NMR 13 and X-ray structures 14 of drug-bound and detergent solubilized
M2 peptide show different kinks of the helical backbone. Comparing the same segments of
27–33 and 35–41, the solution NMR structure (PDB: 2RLF) has a minor kink of 4°, while
the refined crystal structure (PDB: 3C9J) has a larger kink of 12°. Thus, the amt2 kink of 5°
measured by MAS-SSNMR falls within the range of reported by all methods.
Paradoxically, the structure of the apo M2 peptide is much less known than that of the drug-
bound M2. Static 15N NMR data of the apo peptide suffered from broad linewidths due to
unfavorable conformational dynamics of the protein 18; 32, which made it difficult to detect
possible helix orientation differences between the N- and C-terminal segments of the helix.
The MAS-NMR approach here bypasses this difficulty since its main structural constraints
are isotropic chemical shifts, which can be measured at low temperature where motion is
frozen. Based on the 13C and 15N isotropic chemical shifts, the helical backbone of the apo
M2TMP is also not straight but has a kink of ~9°, as shown in the top view in Figure 12b.
While the chemical shift constrained backbone conformation are only indirect constraints of
the helix orientation, the data nevertheless suggests that the presence of Gly34 in the peptide
may cause a small kink already in the apo protein. This would not be surprising since Gly is
a helix breaker in globular proteins 33. In membrane proteins Gly adheres to more ideal
helical torsion angles 34, as in the case of Gly34, but a small deviation from ideality is all
that is required to cause a small kink of the helical axis. If confirmed, then the role of helix
kink to the M2 channel activity would need to be considered. Since Gly34 is located roughly
one turn away from His37, which is responsible for proton conduction, we speculate that the
kink may be required for establishing the proper His37 sidechain conformation. The change
in the helix kink after amantadine binding may thus be relevant for proton blockage.
Backbone structure of the M2 tetramer
Based on the chemical shift constrained monomer structure, we now construct a tetramer
model of amantadine-bound M2TMP using the measured helix orientation and interhelical
distances. Again, the helix tilt angle is set to be 35° for the apo peptide 20 and 38° for the
amantadine-bound peptide 19; 21 for the segment N-terminal to Gly34. We have previously
measured two 19F-19F interhelical distances at Trp41 5-19F 23 and Phe30 4-19F 22; 35
using 19F spin diffusion NMR 36. By design, these experiments measure all three distances
in the symmetric tetramer, including two nearest neighbor i − i±1 distances rnn and the
diagonal i − i+2 distance, . The tetrameric nature of the channel is directly confirmed
in the experiment as an equilibrium value of 1/4. We found an rnn of 11.8 Å for Trp41 5-19F
and 8.5 Å at Phe30 4-19F. The former constrained the Trp41 sidechain rotamer to t90
(χ1=180°, χ2=90°), while the latter constrained the Phe30 rotamer to t (χ1=180°). In addition
to these two interhelical distances, we use a Gly34 Cα-Cα diagonal distance of 10.4 Å 37 in
building the tetramer model.
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Figure 13 shows the tetramer model for the amt2 peptide where the three distance restraints
are indicated. For clarity we show only the diagonal distances, which are 16.7 Å, 12.5 Å,
and 10.4 Å for Trp41 5-19F, Phe30 4-19F, and Gly34 Cα, respectively. For comparison, the
tetramer structure solved by 15N static NMR (PDB: 2H95), solution NMR (PDB: 2RLF),
and X-ray crystallography (PDB: 3C9J) are shown in Figure 14b-d. A number of differences
can be seen. First, both the solution NMR structure in DHPC micelles and the static 15N
NMR structure in DMPC bilayers give inter-helical Trp41 distances that are much shorter
than the measured value. This discrepancy is mainly due to the different (χ1, χ2) angles in
these models: t-90 in the solution NMR structure and (−95°, 125°) in the static 15N NMR
model. The crystal structure has the t90 rotamer for Trp41 and thus gives consistent
interhelical distances with the 19F MAS NMR result. Second, the MAS-SSNMR tetramer
model is more open at the N-terminus than the solution NMR and crystal structures. At
Val27, the Hγ - Hγ diagonal distances in our model are ~11 Å, but are 5 – 7 Å in the other
models. The relatively large pore opening at Val27 in our model is a direct result of the helix
orientation, and is consistent with the small chemical shift perturbation of Val27 and the
interhelical Phe30 distance constraint. This large opening may be necessary to allow the drug
to bind at the N-terminus. The smaller Val27 constriction in the solution NMR and crystal
structures is a direct result of smaller tilt angles, which may be influenced by the detergent
matrix used. It is well documented that the orientation of the M2 transmembrane helix is
relatively plastic, readily affected by the bilayer thickness 20; 38. In DLPC and DMPC
bilayers, both MAS and static NMR experiments point to a large helical tilt angle of about
35°, while in POPC bilayers the tilt angle is only 26° 20.
In contrast to the openness of the channel at Val27, the MAS-derived structural model shows
a tight Ser31 constriction, with a distance of 9.0 Å between the two opposing hydroxyl
oxygens. This Ser31 constriction is similar to the crystal structure, but tighter than the
static 15N NMR model (11.9 Å) and the solution NMR structure (19.4 Å) (Figure 14).
Overall, the small Ser31 constriction is consistent with the large chemical shift perturbation
at this site (see next section).
To compare the various M2 PDB structures with the current MAS-based model more
quantitatively, we used the SHIFTX program 39 to calculate the 15N, 13CO, 13Cα and 13Cβ
chemical shifts for the crystal structure (PDB: 3C9J), the solution NMR structure (PDB:
2RLF), and the oriented solid-state NMR structure (PDB: 2H95). The root-mean-square
(RMS) deviations of the predicted chemical shifts from the measured values for both the apo
and amantadine-bound M2TMP are summarized in Table S2 (Supplementary Material).
Three observations can be made. First, with the exception of the 13CO shifts for the oriented
NMR structure model, most 13C RMS shift differences are in the range of 0.8–1.3 ppm,
which are comparable to the standard RMS errors of the SHIFTX program. This suggests
that the deviations are mostly due to systematic uncertainties in the prediction protocol
rather than large secondary structure differences. Second, the 15N chemical shifts
differences are comparable to the standard RMS error when the predicted values are
compared to the measured apo chemical shifts, but the differences become almost two times
larger when the predicted values are compared to the amantadine-bound chemical shifts.
This further indicates the sensitivity of 15N chemical shifts to long-range electrostatic effects
due to ligand binding and helix packing, which are not taken into account in such chemical
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shift prediction programs. Third, among the three PDB structures, the oriented SSNMR
structure (2H95) has the largest 13C chemical shift deviations from the current data, but the
smallest 15N chemical shift deviations. This is consistent with the sole use of 15N NMR
inputs to constrain the 2H95 model.
Ser31 interaction with amantadine
The chemical shift perturbation plot (Figure 7a) indicates maximal drug-induced changes at
Ser31 and Val28, which are mainly due to the large 15N chemical shift changes of these two
residues. Many factors influence 15N chemical shielding: in addition to (ϕ, ψ, χ) torsion
angles 40, solvation effects and electrostatic field effects can be significant. Hydrogen
bonding of the NH group can cause a deshielding of as much as 13 ppm 41, and γ-gauche
effect through the sidechain torsion angle also affects the 15N chemical shifts 40. However,
database 15N secondary shifts show only small deviations of ~ 1 ppm for the helical
conformation from the random coil values 42. Thus, it is difficult to directly interpret the
large 15N chemical shift perturbation of Ser31. Nevertheless, it is noteworthy that both
the 15N and Cβ chemical shifts of Ser31 in the bound peptide (Table 1) are well beyond the
typical values for α-helical Ser 42, which are 114.9 ppm and 61.2 ppm, respectively, while
the apo peptide’s Ser31 chemical shifts are within the database range for α-helical Ser. This
suggests that Ser31 is locally perturbed by amantadine through packing effects.
Early neutron diffraction 25 and MD simulations 24 both supported the N-terminus of the
helical bundle to be the amantadine binding site. However, the recently published high-
resolution crystal structure 14 and solution NMR structure 13 of M2 gave contradictory
results on the drug binding site. The former shows an N-terminus binding site deeper than
Ser31, while the latter puts four rimantadine molecules per channel on the C-terminus side at
helical interfaces. Since then, a functional study of the proton conductivity of M2 mutants
has been carried out that supports the N-terminus region as the primary amantadine binding
site with channel inhibition properties 43.
While the current data do not directly probe the drug binding site, several indirect pieces of
structural evidence support an N-terminus location for amantadine. First, Ser31 is the only
residue among the three studied here whose sidechain Cβ linewidth is reduced. This may
reflect sidechain conformational ordering necessary to form the appropriate hydrogen bond
with amantadine. Second, the chemical shift perturbation for the segment N-terminal to G34
is extensive (Figure 11), with only the lipid-facing A29 and the very upstream L26 showing
no torsion angles changes. Third, both V28 and L36 lie at lipid-facing positions (b and c) of
the heptad repeat, but the chemical shift perturbation of the N-terminus V28 is much larger
than that of the C-terminus L36.
Assuming that amantadine indeed binds the N-terminus portion of the channel, we can
model the distances of amantadine from Ser31 in the tetramer (Figure 15). Using the height
of amantadine found in the crystal structure as a template, we found that if the amine points
to the center of the membrane, then the RNO distances between Ser31 OH and amantadine
NH2 are 7.5 – 8.0 Å, too long for hydrogen bonding. However, if the amine points to the
membrane surface, then much shorter RNO distances of ~4.5 Å are found. This amine-up
orientation is supported by a recent paramagnetic relaxation NMR and MD simulation study
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of the depth of insertion of amantadine in the absence of M2 30. To decrease the RNO
distance further to form hydrogen bonds of 2.5 – 3.5 Å, the Ser31 χ1 torsion angle would
need to be changed. Due to the small sidechain, Ser does not have a single dominant χ1
rotamer. For α-helical backbones, the most popular rotamer of m (χ1= −65°) is 44% while
the least popular rotamer t (χ1=−170°) still has a significant presence of 22% 44. In our
model (Figure 15), both the m and t rotamers give RNO distance of ~4.5 Å, but shorter
distances of ~3.5 Å may be reached for less canonical χ1 angles. Ultimately, intermolecular
distance experiments are necessary to test this Ser31 binding-site hypothesis and to
determine the high-resolution structure of the amantadine binding pocket in the bilayer-
bound M2.
Molecular dynamics of M2TMP
The conformational plasticity of the M2 peptide in lipid membranes are now well
documented 20; 32; 38. The low 13C CP intensities and short 13C T2 relaxation times for V28,
S31 and L36 at high temperature all confirm the presence of intermediate-timescale
conformational dynamics, which interfere with 1H decoupling and the 1H-13C cross
polarization process. In the gel phase, the motion is largely frozen, thus the distribution of
conformations sampled at high temperature is shown as isotropic chemical shift
distributions. The larger low-temperature linewidths of the apo peptide compared to the
complexed peptides, mostly at 15N sites, indicate larger conformational disorder of the apo
peptide.
The nature of the M2 motion is complex. We have shown that the whole helical bundle
undergoes uniaxial rotation around the bilayer normal 20, which explains the observation
that the short 13C T2 times are not local but occur throughout the peptide. The lengthening
of the T2 upon amantadine binding (Table 3) can in principle result from either a decrease or
increase of motional correlation times. Temperature-sensitive relaxation times (unpublished
data) indicate that the rate of motion is accelerated rather than slowed down by amantadine.
Figure 7b indicates that most residues have similar amantadine-induced T2 increases except
for Ser31 and Val27, whose T2 increases are much larger. We hypothesize that the
exceptionally long 13C T2 at this two sites may be caused by strong interaction with
amantadine. However, the exact nature of the site-specific conformational dynamics or
ordering will require further investigation.
In summary, the solid-state NMR chemical shifts and dynamic constraints measured here for
Ser31 and other residues combine with previous data to allow the determination of a bilayer-
bound structure of the transmembrane domain of this important influenza proton channel.
We found that the apo and amantadine-complexed M2TMP differ in conformation mainly at
three regions, V27-V28, A30-S31, and G34-I35. In particular, G34 is the site of a helical
kink in both the apo and drug-bound peptide. Interhelical distances and helix orientations
constrain the tetramer to be relatively open at the N-terminus, which allows the drug to
enter, but tight at Ser31, which suggests hydrogen bonding between the hydroxyl group and
the amantadine amine. At Trp41 the channel has an interhelical distance of ~16.7 Å between
opposing helices. Among all residues, Ser31 shows the largest drug-induced perturbations of
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chemical shifts, conformational dynamics, and conformational disorder, strongly suggesting
that this residue is the amantadine binding site.
Material and Methods
Peptides and lipids
Fmoc-protected uniformly 13C, 15N-labeled Val, Ser, and Leu were either prepared in-
house 45 or purchased from Sigma-Aldrich and Cambridge Isotope Laboratories. The M2
transmembrane domain of the Udorn strain (residues 22–46) 46 was synthesized by
PrimmBiotech (Cambridge, MA) and purified to >95% purity. The amino acid sequence is
SSDPL VVAASII GILHLIL WILDRL. The main peptide used in this work includes labeled
residues at V28, S31, and L36 and is denoted VSL-M2TMP. Two previously studied
M2TMP samples were also reexamined for their chemical shift assignment. One peptide
contains labeled residues at L26, A29, G34 and I35, and the other peptide contains labeled
sites at V27, A30, I33 and L38.
Membrane sample preparation
M2TMP was reconstituted into 1,2-dilauroyl-sn-glycero-3-phosphatidylcholine (DLPC)
bilayers by detergent dialysis 23. DLPC was chosen because of the favorable dynamics of
the protein in this membrane 20 and the similar phase transition temperature (−2°C) of this
bilayer to biological cell membranes. The lipid vesicle solution was prepared by suspending
dry DLPC powder (Avanti Polar Lipids) in 1 mL phosphate buffer (10 mM Na2HPO4/
NaH2PO4, 1 mM EDTA, 0.1 mM NaN3) at pH 7.5, vortexing and freeze-thawing 6–8 times
to create uniform vesicles 47. M2TMP powder was codissolved with OG in 2 mL phosphate
buffer to an OG concentration of 30 mg/mL. The M2TMP/OG solution was mixed with an
equal volume of DLPC vesicles to halve the OG concentration to 15 mg/mL. The final
peptide/lipid molar ratio (P/L) was 1:15. The mixture was vortexed for 1 hr, allowed to stand
for 6–8 hrs at room temperature, then dialyzed with a 3.5 kDa cutoff against 1 L phosphate
buffer at 4°C for 3 days. The buffer was changed every 8–12 hrs to ensure complete removal
of the detergent. The dialyzed M2TMP/DLPC solution was centrifuged at 150,000 g for 3
hours at 10°C, resulting in a pellet containing ~50 wt% water. For most amantadine-bound
samples, 10 mM amantadine hydrochloride was added to the phosphate buffer either
throughout the vesicle formation and peptide reconstitution processes or before
ultracentrifugation. After ultracentrifugation the percent of amantadine left in the
supernatant was quantified by 1H solution NMR and found to be roughly 60%. This gave a
peptide : lipid : drug molar ratio of about 1 : 15 : 8. All membrane-bound M2 samples were
thus studied at pH 7.5, corresponding to the closed state of the channel.
Solid-state NMR spectroscopy
Most SSNMR experiments were carried out on a Bruker AVANCE-600 (14.1 Tesla)
spectrometer (Karlsruhe, Germany) using a 4 mm triple-resonance MAS probe. 13C-13C
and 15N-13C 2D correlation experiments were conducted at 243 K to freeze peptide
motion. 13C T2 relaxation times were measured at 303 K where the peptide is uniaxially
mobile in the liquid-crystalline DLPC bilayer. Typical rf pulse lengths were 5 μs for 13C and
3.5–4.0 μs for 1H. 1H TPPM 48 or SPINAL 49 decoupling field strengths of 60 – 70 kHz
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were applied. 13C chemical shifts were referenced to the α-Gly C′ signal at 176.49 ppm on
the TMS scale, and 15N chemical shifts were referenced to the 15N signal of N-acetyl-valine
at 122.0 ppm on the liquid ammonia scale.
Three types of 2D 13C-13C correlation experiments were carried out to assign all regions of
the 13C spectra. A double-quantum-filtered (DQF) COSY experiment was used to obtain
lipid-free protein spectra. Double-quantum filtration was performed using the dipolar
recoupling sequence SPC5 50 with the sample spun at 7000 Hz. To better assign the
carbonyl peaks, which are weak in the DQF-COSY spectrum due to their large chemical
shift difference from the aliphatic carbons, a 2D 1H-driven 13C spin diffusion experiment
with a 10 ms DARR mixing period 51 was carried out under 5333 Hz MAS. Finally, to
completely resolve the sidechain methyl 13C signals, a double-quantum single-quantum
correlation experiment, INADEQUATE 52; 53, was used in which the SPC5 sequence was
again used for double-quantum excitation and reconversion.
Heteronuclear 2D 15N-13C correlation experiments were carried out in an out-and-back
fashion using the REDOR sequence 54 for 13C-15N coherence transfer 55. The C-N
recoupling times varied between 0.7 and 2.1 ms to observe one-bond versus multiple-bond
cross peaks.
To selectively detect the S31 Cβ signal that overlaps with its Cα, we carried out a methylene
spectral editing experiment 56 at 233 K. The β pulse in the sequence that was responsible for
clean suppression of the methine CH signals was optimized to be 40°. For MREV-8 57 1H
homonuclear decoupling, a 1H pulse flip angle of 94° was used.
Structure Modeling
The M2TMP tetramer structure was modeled in Insight II (Accelrys, Inc. San Diego). The
central segment of residues 26–38 was constrained by the chemical shifts and interhelical
distances except for residues I32 and H37. The final tetramer model used the wild-type
residue Ala at position 30, after the mutation Phe30 was checked for interhelical distance
restraint. The atomic coordinates of the tetrameric helical bundle have been deposited in the
Protein Data Bank (accession number: 2kad). The SSNMR chemical shift restraints have
been deposited in the Biological Magnetic Resonance Bank (accession number: 16020).
These data will be released upon publication.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
M2(22–46) sequence and its representation as a heptad repeat. (a) Amino acid sequence. The
a and d residues of the heptad repeat abcdefg are labeled. The 13C, 15N-labeled residues that
have been studied so far 19 are colored in red. H37 and W41, which are central for proton
conduction and channel gating, are shown in blue. (b) Four-helix bundle organization of
M2TMP. Channel-facing a and d residues are shaded in pink, and interfacial e and g
residues are shaded in cyan.
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Figure 2.
1D 13C spectra of VSL-M2TMP in DLPC bilayers at 243 K. (a) 13C DQF spectrum of the
apo peptide. (b) 13C DQF spectrum of the amantadine-bound peptide. (c) 15N-filtered 13C
spectrum of the apo peptide. (d) 15N-filtered 13C spectrum of the amantadine-bound peptide.
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Figure 3.
2D 13C-13C DQF correlation spectra of VSL-M2TMP in DLPC bilayers at 243 K without
(black) and with (red) amantadine. (a) Aliphatic region. (b) S31 and V28 region. (c)
Carbonyl region.
Cady et al. Page 20
J Mol Biol. Author manuscript; available in PMC 2014 August 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4.
Selective detection of S31 Cβ by CH2 editing. (a) 13C CP-MAS spectrum of apo-M2TMP.
(b) CH2 edited spectrum of apo-M2TMP. (c) 13C CP-MAS spectrum of amantadine-bound
M2TMP. (d) CH2 edited spectrum of bound M2TMP. Note the suppression of the Cα CH
peaks in (b) and (d).
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Figure 5.
1D 15N CP-MAS spectra of VSL-M2TMP in DLPC bilayers at 243 K. (a) Without
amantadine. (b) With amantadine.
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Figure 6.
(a) 2D 15N-13C 2D correlation spectrum of VSL-M2TMP in DLPC bilayers at 243 K. Black:
without amantadine. Red: with amantadine. (b) S31 15N cross sections.
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Figure 7.
Amantadine-induced changes of M2TMP structure and dynamics in DLPC bilayers. (a)
Average isotropic chemical shift changes for each residue, measured at low temperature. (b)
Average 13C T2 changes, measured at 303 K.
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Figure 8.
1D 13C variable-temperature CP-MAS spectra of VSL-M2TMP bound to DLPC bilayers. (a)
Without amantadine. (b) With amantadine. Temperatures from top to bottom are 313 K, 283
K and 243 K.
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Figure 9.
2D 15N-13C correlation spectra of VSL-M2TMP in DLPC bilayers with different amounts of
amantadine. The S31 15N-13Cα cross peak is used to indicate the degree of amantadine
binding. 1D 15N CP spectra are shown projected from the indirect dimension of each
spectrum. (a) No amantadine. The S31 peak is completely in the unbound position. (b)
Amantadine added at 10 mM in the buffer. The M2 : amantadine molar ratio in the final
membrane is ~1 : 8. Almost all S31 intensities are at the bound position. (c) Amantadine
directly titrated into the membrane pellet. The M2 : amantadine molar ratio in the final pellet
is ~ 1 : 2. 70% of the S31 intensity is at the bound position.
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Figure 10.
Fractional 13C T2 changes of DLPC lipid carbons upon amantadine binding at 313 K. No
M2 peptide is present. The fractional change is calculated as .
Cady et al. Page 27
J Mol Biol. Author manuscript; available in PMC 2014 August 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 11.
TALOS predicted (ϕ, ψ) angles for residues 26–38 of apo (black) and amantadine-
complexed M2TMP (red). Filled and open red symbols denote the conformations of amt1
and amt2, which differ at G34. Residues 32 and 37 are shaded due to incomplete
experimental data.
Cady et al. Page 28
J Mol Biol. Author manuscript; available in PMC 2014 August 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 12.
Chemical shift constrained backbone structure of the M2TMP monomer. Apo: black and
gray ribbon. Amantadine-bound: blue and cyan ribbon. (a) Side view of the helix with tilt
angles determined by SSNMR. (b) Top view of the apo monomer. (c) Top view of the
amantadine-complexed monomer. The apo peptide has a more noticeable kink.
Cady et al. Page 29
J Mol Biol. Author manuscript; available in PMC 2014 August 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 13.
Tetramer model of M2TMP constrained by SSNMR chemical shifts, interhelical distances
and helix orientations. (a) Trp41 5-19F distance between the two opposite helices is 16.7
Å 23. (b) Phe30 4-19F diagonal distance is 12.5 Å 22. (c) Side view of the tetramer, with a
diagonal Gly34 Cα-Cα distance of 10.4 Å.
Cady et al. Page 30
J Mol Biol. Author manuscript; available in PMC 2014 August 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 14.
Comparison of the MAS NMR structure model with other recently published structures of
drug-complexed M2. The Trp41 indole ring and the diagonal distance between its 5-19F or
Hζ3 is indicated. (a) MAS-NMR model of amantadine-bound M2TMP. (a) 15N static
SSNMR model of amantadine-bound M2TMP (PDB code: 2H95). (b) Solution NMR
structure of rimantadine-bound M2(18-60) (PDB code: 2RLF). (c) Crystal structure of
amantadine-bound M2TMP (PDB: 3C9J).
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Figure 15.
MAS-NMR M2 tetramer model with the proposed amantadine-binding site. The height of
amantadine is set to be similar to that of the crystal structure. Ser31 sidechain O distances to
the amine are indicated. The top view looks down the helix axis from the N- to the C-
terminus.
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Table 3
13C homogeneous T2 (ms) of VSL-M2TMP at 303 K with 71 kHz 1H decoupling.
Residue site T2, apo T2, +Amt
V28 Cα 1.0 2.5
Cγ1 3.0 5.6
Cγ2 2.6 4.7
S31 Cα
1.1
3.5
Cβ 3.8
L36 Cα 1.0 3.6
Cβ 1.1 3.5
Cγ 2.6 7.9
Cδ1 6.0 11.6
Cδ2 6.0 -
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